It was addressed on the CC. Basically it was 2 reasons. One being that he didn't want to put out images that weren't the ones he sent to the FDA. Dean was concerned about causing confusion or discrepancies this close to FDA approval. Secondly he was lightly concerned about other companies trying to mimic or learn something from the picutures that they could use to enhance their product(s).
News 
Market Data 
Discover 
AI
